Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
02/2000
02/17/2000CA2339270A1 Triazolone derivatives, use thereof, and intermediate therefor
02/17/2000CA2339018A1 Fsh mimetics for the treatment of infertility
02/17/2000CA2339007A1 Crystalline forms of osanetant
02/17/2000CA2338944A1 Succinoylamino lactams as inhibitors of a.beta. protein production
02/17/2000CA2338594A1 Imidazoles and related compounds as .alpha.1a agonists
02/17/2000CA2338121A1 Amide derivatives useful as inhibitors of the production of cytokines
02/16/2000EP0979823A1 Novel amide compounds and drugs containing the same
02/16/2000EP0979822A1 Process for the preparation of 2-carbamoyl-pyridines
02/16/2000EP0979229A1 2-oxo-1-azetidine sulfonic acid derivatives as potent beta-lactamase inhibitors
02/16/2000EP0979228A1 Novel cannabinoid receptor agonists
02/16/2000EP0979079A1 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination
02/16/2000EP0979077A1 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
02/16/2000EP0870767B1 1-(5-isoquinolinesulfonyl)homopiperazine hydrochloride hydrates
02/16/2000CN1244867A Substitued nitrogen containing heterocycles as inhibitors of P38 protein kinase
02/16/2000CN1244798A Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
02/16/2000CN1244528A Di- Or triaza-spiral [4,5] decane derivative
02/16/2000CN1049434C Aromatic amidine derivatives and method for preparing medicinal salts thereof
02/16/2000CN1049430C Sulfonamides and its preparing method and use thereof
02/15/2000US6025496 Process for preparing heterocyclic carbenes
02/15/2000US6025478 High reactivity and fixing capacity, good low temperature dyeing, good color intensity, lightfastness, washfastness
02/15/2000US6025472 N-substituted glycine derivatives as enzyme inhibitors
02/15/2000US6025378 Antiatherosclerotic action.
02/15/2000US6025372 Somatostatin agonists
02/15/2000US6025370 Quinolonecarboxylic acid derivatives or salts thereof
02/15/2000US6025367 Sulfonamide derivatives as 5HT7 receptor antagonists
02/15/2000US6025355 Substituted indolinyl and derivatives thereof, neurological injury and neurodegenerative disorders.
02/15/2000CA2197739C 1,4-dihydropyridine compounds
02/15/2000CA2152792C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
02/15/2000CA2109585C Isoxazole and isothiazole compounds that enhance cognitive function
02/10/2000WO2000006565A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
02/10/2000WO2000006564A1 Disubstituted maleimide compounds and medicinal utilization thereof
02/10/2000WO2000006563A1 Substituted imidazoles having cytokine inhibitory activity
02/10/2000WO2000006545A1 High affinity ligands for nociceptin receptor orl-1
02/10/2000WO2000006544A1 Cyclic amine derivatives and process for the preparation thereof
02/10/2000WO2000006531A2 Nitric esters and nitrate salts of specific drugs
02/10/2000WO2000006529A1 Diketoacid-derivatives as inhibitors of polymerases
02/10/2000WO2000006173A1 5-ht1f agonists
02/10/2000WO2000006169A1 Integrin receptor antagonists
02/10/2000WO2000006167A1 Tricyclic compounds
02/10/2000WO2000006166A1 5-ht1f antagonists
02/10/2000WO2000006146A1 Substituted anilide compounds and methods
02/10/2000WO2000006085A2 Compounds and methods
02/10/2000WO2000006082A2 Treatment of anxiety disorders
02/10/2000WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors
02/10/2000WO1999063939A3 Multibinding inhibitors of cyclooxygenase-2
02/10/2000CA2338866A1 Disubstituted maleimide compound and pharmaceutical use thereof
02/10/2000CA2338764A1 Substituted anilide compounds and methods
02/10/2000CA2338740A1 Treatment of anxiety disorders
02/10/2000CA2338697A1 Compounds and methods
02/10/2000CA2338490A1 Diketoacid-derivatives as inhibitors of polymerases
02/10/2000CA2338298A1 Tricyclic compounds
02/10/2000CA2338275A1 Integrin receptor antagonists
02/09/2000EP0978514A1 Indazole derivatives as 5-HT1F agonists
02/09/2000EP0978392A1 Optical recording media
02/09/2000EP0977989A1 4-substituted-quinoline derivatives and 4-substitute-quinoline combinatorial libraries
02/09/2000EP0977756A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
02/09/2000EP0977751A1 Somatostatin agonists
02/09/2000EP0977750A1 Farnesyltransferase inhibiting quinazolinones
02/09/2000EP0977748A1 Substituted benzopyran derivatives for the treatment of inflammation
02/09/2000EP0977745A1 Thioaryl sulfonamide hydroxamic acid compounds
02/09/2000EP0977741A1 Substituted phenyl derivatives, their preparation and use
02/09/2000EP0977740A1 Methods for synthesizing 2-substituted imidazoles
02/09/2000EP0977737A1 Crf antagonistic quino- and quinazolines
02/09/2000EP0977600A2 Contrast agents
02/09/2000EP0822934B1 Antithrombotic amidinotetrahydropyridylalanine derivatives
02/09/2000CN1244194A Phenylsulphonyl ureas, processes for their preparation and their use as herbicides and plant-growth regulators
02/09/2000CN1244124A Amorphous benzothiophenes, methods of preparation, and methods of use
02/09/2000CN1244122A Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
02/09/2000CN1243828A Cationic polypeptide condensing agent of pyridine, its synthesizing process and its application
02/09/2000CN1049219C Fused heteroaromatic cyclopentene derivative having endothelin-antagonist activity
02/08/2000US6022996 Method for making intermediates useful in synthesis of retroviral protease inhibitors
02/08/2000US6022971 Azetidines
02/08/2000US6022967 Heterocyclic compounds
02/08/2000US6022884 Substituted pyridine compounds and methods of use
02/08/2000US6022880 Substituted pyridylamino indoles
02/08/2000US6022875 Use of substituted 2,4-imidazolidinedione compounds as analgesics
02/08/2000US6022869 Aminoheterocyclic compounds with antithrombotic/anticoagulant effect
02/08/2000US6022523 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
02/08/2000US6022492 Difluorophenyl pyrimidyl pyridine derivatives and the use thereof in liquid crystal mixtures
02/08/2000CA2150016C Pyrrolopyrimidines as crf antagonists
02/08/2000CA2095587C Process for preparing aryl piperazinyl-hetero-cyclic compounds
02/08/2000CA2090942C Anti-tumour compounds containing quinazoline and tetrazole rings
02/08/2000CA2014467C 3-substituted-2-oxindole derivatives
02/08/2000CA2012495C Poly(1-hydrocarbyloxy-2,2,6,6-tetraalkylpiperidine) light stabilizers
02/06/2000CA2279747A1 Estrogen agonists/antagonists
02/03/2000WO2000005232A1 Heterocyclic compounds as inhibitors of rotamase enzymes
02/03/2000WO2000005231A1 Fkbp inhibitors
02/03/2000WO2000005229A1 Phenylindole derivatives as 5-ht2a receptor ligands
02/03/2000WO2000005225A1 Biphenyl derivatives
02/03/2000WO2000005222A1 Dihydrotriazolone derivatives as pesticides
02/03/2000WO2000005219A1 Phthalazine derivatives as phosphodiesterase 4 inhibitors
02/03/2000WO2000005218A1 Phthalazine derivatives phosphodiesterase 4 inhibitors
02/03/2000WO2000005215A1 A process for preparing benzocycloheptapyridin-11-ones
02/03/2000WO2000005214A2 Isoquinolines as urokinase inhibitors
02/03/2000WO2000005210A1 N,n-substituted cyclic amine derivatives
02/03/2000WO2000005208A1 Amino-aldehyde solid support, linker therefor and methods of preparation and use thereof
02/03/2000WO2000005206A1 Arylpiperazine derivatives useful as uro-selective alpha-1-adrenoceptor blockers
02/03/2000WO2000005205A1 Arylpiperazine derivatives useful as uroselective alpha1-adrenoceptor blockers
02/03/2000WO2000004904A1 Pharmaceutical compositions comprising hydroxylansoprazole and uses thereof
02/03/2000WO2000004900A1 Substituted benzimidazole antiviral agents